Correlation Between Meitav Dash and BioLine RX
Can any of the company-specific risk be diversified away by investing in both Meitav Dash and BioLine RX at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Meitav Dash and BioLine RX into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Meitav Dash Investments and BioLine RX, you can compare the effects of market volatilities on Meitav Dash and BioLine RX and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Meitav Dash with a short position of BioLine RX. Check out your portfolio center. Please also check ongoing floating volatility patterns of Meitav Dash and BioLine RX.
Diversification Opportunities for Meitav Dash and BioLine RX
-0.94 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Meitav and BioLine is -0.94. Overlapping area represents the amount of risk that can be diversified away by holding Meitav Dash Investments and BioLine RX in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BioLine RX and Meitav Dash is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Meitav Dash Investments are associated (or correlated) with BioLine RX. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BioLine RX has no effect on the direction of Meitav Dash i.e., Meitav Dash and BioLine RX go up and down completely randomly.
Pair Corralation between Meitav Dash and BioLine RX
Assuming the 90 days trading horizon Meitav Dash Investments is expected to generate 0.25 times more return on investment than BioLine RX. However, Meitav Dash Investments is 4.08 times less risky than BioLine RX. It trades about 0.67 of its potential returns per unit of risk. BioLine RX is currently generating about -0.42 per unit of risk. If you would invest 304,500 in Meitav Dash Investments on October 21, 2024 and sell it today you would earn a total of 65,600 from holding Meitav Dash Investments or generate 21.54% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Meitav Dash Investments vs. BioLine RX
Performance |
| Timeline |
| Meitav Dash Investments |
| BioLine RX |
Meitav Dash and BioLine RX Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Meitav Dash and BioLine RX
The main advantage of trading using opposite Meitav Dash and BioLine RX positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Meitav Dash position performs unexpectedly, BioLine RX can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioLine RX will offset losses from the drop in BioLine RX's long position.| Meitav Dash vs. Amanet Management Systems | Meitav Dash vs. Opko Health | Meitav Dash vs. Isras Investment | Meitav Dash vs. Adgar Investments and |
| BioLine RX vs. Evogene | BioLine RX vs. Enlivex Therapeutics | BioLine RX vs. Kamada | BioLine RX vs. Compugen |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Other Complementary Tools
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Stocks Directory Find actively traded stocks across global markets | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |